Department of Gastroenterology, Shandong Provincial Hospital affiliated to Shandong University, No. 324, Jingwuweiqi Road, Jinan, Shandong, China.
BMC Gastroenterol. 2019 Nov 6;19(1):174. doi: 10.1186/s12876-019-1099-5.
To compare the outcomes of submucosal tunneling endoscopic resection (STER) and submucosal excavation (ESE) for the treatment of submucosal tumors (SMTs) arising from the muscularis propria (MP) at the esophagogastric junction (EGJ).
A retrospective analysis of patients with SMTs at EGJ who underwent STER and ESE from October 2011 to October 2017 was performed. The outcomes evaluated were operation time, complete resection rate, adverse events, and tumor recurrence.
Ninety patients were included in this study. Complete resection rates in the STER group were higher than those of the ESE group (100 vs. 92%, p < 0.05). For tumors ≤15 mm, both techniques achieved 100% complete resection rate; but for tumors > 15 mm, complete resection rate was higher in the STER group than the ESE group (100% vs. 77.8%, p < 0.05). Subgroup analyses revealed that the operation time of STER for in cardiac-gastric group was longer than that for ESE (145.14 ± 42.43 min vs. 70.32 ± 39.84 min, p < 0.05). The air leakage symptoms were more frequent in STER group (90.9% vs. 50.0%, p < 0.05). No tumor recurrence occurred in both the STER and ESE groups.
For SMTs ≤15 mm, both STER and ESE have similar satisfactory therapeutic outcomes. However, in the cardiac-gastric subgroup, STER had a longer operative time compared to the ESE procedure. For SMTs > 15 mm, STER is the preferred choice due to its higher complete resection rate.
比较经黏膜下隧道内镜切除术(STER)和黏膜下挖除术(ESE)治疗食管胃结合部固有肌层黏膜下肿瘤(SMTs)的疗效。
回顾性分析 2011 年 10 月至 2017 年 10 月期间行 STER 和 ESE 治疗食管胃结合部 SMTs 的患者。评估的结果包括手术时间、完全切除率、不良事件和肿瘤复发。
本研究共纳入 90 例患者。STER 组的完全切除率高于 ESE 组(100%比 92%,p < 0.05)。对于≤15 mm 的肿瘤,两种技术的完全切除率均为 100%;但对于>15 mm 的肿瘤,STER 组的完全切除率高于 ESE 组(100%比 77.8%,p < 0.05)。亚组分析显示,STER 治疗贲门旁 SMTs 的手术时间长于 ESE(145.14±42.43 min 比 70.32±39.84 min,p < 0.05)。STER 组的气漏症状更为常见(90.9%比 50.0%,p < 0.05)。STER 和 ESE 组均无肿瘤复发。
对于≤15 mm 的 SMTs,STER 和 ESE 均有相似的满意治疗效果。然而,在贲门旁亚组中,STER 的手术时间长于 ESE 手术。对于>15 mm 的 SMTs,由于完全切除率较高,STER 是首选。